COVID-19和心脏病之间的相互作用:揭开一个复杂的连接
G D Duerr1, M Hamiko2, J Beer1
1Department of Cardiovascular Surgery, University Medical Center, Johannes-Gutenberg University, Mainz, Germany.
Life sciences
|March 5, 2025
概括
这项研究确定了心脏病患者严重COVID-19结果的关键预测因素. 循环单细胞和C反应蛋白水平有助于预测心肌损伤和存活率,有助于临床实践.
科学领域:
- 心脏病学 心脏病学
- 传染性疾病 传染性疾病
- 免疫学 免疫学 免疫学
背景情况:
- COVID-19对已有心脏病患者构成重大风险.
- SARS-CoV-2 感染可以直接导致心脏损伤,包括心肌炎和心力衰竭.
- 识别患有严重心脏并发症风险的患者和预测COVID-19严重程度至关重要.
研究的目的:
- 根据临床和免疫学参数对COVID-19患者进行分层.
- 为了确定心肌损伤 (心周溢血 - PE) 和疾病严重程度的预测因素.
- 评估用于预测COVID-19患者结果的机器学习算法.
主要方法:
- 对134名SARS-CoV-2阳性患者的临床和免疫学数据的分析.
- 疾病严重程度的分层分为三个类别 (SWOSS A-C).
- 机器学习算法用于识别PE和生存的预测标记.
主要成果:
- 周心输出 (PE) 和SWOSS-C与降低生存率有关.
- CD14+ HLA-DR+单细胞是心肌损伤 (PE) 的最强预测因素.
- C-反应蛋白 (CRP) 是PE和SWOSS类别的关键预测因素;SWOSS类别预测了生存率.
结论:
- 简化严重程度分类 (SWOSS) 有助于临床实践.
- 通过使用临床和免疫学数据,可以识别PE和生存的预测标记.
- 人工智能识别的预后特征提供了对COVID-19和心脏病相互作用的见解.
相关概念视频
Psychoneuroimmunology: Cardiovascular Disease
23
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
23
Ischemic Heart Disease: Overview
1.1K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.1K
Pathophysiology of Heart Failure
1.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
Factors Influencing Heart Rate
2.2K
The heart rate, or pulse rate, is a vital indicator of cardiovascular health. It reflects the number of times the heart beats per minute. Various physiological and environmental factors influence heart rate, increasing or decreasing cardiac output. Understanding these factors is crucial for assessing heart function and identifying potential health issues.
Let us explore the significant factors affecting heart rate, including age, body temperature, posture, acute pain, chemical influences,...
Let us explore the significant factors affecting heart rate, including age, body temperature, posture, acute pain, chemical influences,...
2.2K
Cardiovascular Drugs: Classification based on Therapeutic Indications
2.0K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.0K
Heart Failure Drugs: β-Blockers
306
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
306


